Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...

The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which ...

Luxury goods companies were spared their worst case scenario in Sunday's EU-U.S. trade deal but they face a delicate ...

Bristol Myers Squibb and Bain Capital launch a new biopharma firm focused on autoimmune disease treatments, starting with 5 ...

Anne Hoecker, Bain & Company's head of global technology practice, joins CNBC's 'Squawk on the Street' to discuss the growth ...

The most successful carve-out acquisitions start with due diligence that identifies both the carve-out-specific elements and ...

Bain Capital and Bristol Myers Squibb have formed a new biopharmaceutical company focused on developing new therapies for autoimmune diseases. The newly formed company launches with a $300 million ...

Bain Capital's Bridge Data Centres (Bridge DC) has broken ground on a facility in Thailand. Located south of Bangkok in the ...

Bain Capital’s exit leaves Perpetual negotiating with Oaktree-backed financial planner roll-up AZ Next Generation Advisory.

Delivering accelerated business transformations by leveraging the most advanced technology platforms and solutions ...

We recently compiled a list of 11 Best Undervalued Stocks to Invest in Now. Lincoln National Corporation stands third on our ...